1. Home
  2. ADM vs RMD Comparison

ADM vs RMD Comparison

Compare ADM & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Archer-Daniels-Midland Company

ADM

Archer-Daniels-Midland Company

SELL

Current Price

$82.77

Market Cap

38.6B

ML Signal

SELL

Logo ResMed Inc.

RMD

ResMed Inc.

SELL

Current Price

$242.14

Market Cap

34.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ADM
RMD
Founded
1902
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.6B
34.0B
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
ADM
RMD
Price
$82.77
$242.14
Analyst Decision
Hold
Buy
Analyst Count
11
20
Target Price
$80.20
★ $250.52
AVG Volume (30 Days)
★ 3.0M
967.3K
Earning Date
11-03-2026
10-29-2026
Dividend Yield
★ 2.49%
1.12%
EPS Growth
N/A
★ 9.67
EPS
2.49
★ 10.43
Revenue
★ $80,269,000,000.00
$2,957,013,000.00
Revenue This Year
$8.18
$2.65
Revenue Next Year
$5.07
$6.38
P/E Ratio
$33.61
★ $22.59
Revenue Growth
N/A
★ 13.44
52 Week Low
$55.58
$180.27
52 Week High
$88.75
$277.67

Technical Indicators

Market Signals
Indicator
ADM
RMD
Relative Strength Index (RSI) 51.97 72.68
Support Level $76.65 $217.41
Resistance Level $83.96 $262.39
Average True Range (ATR) 1.89 4.63
MACD 0.20 2.00
Stochastic Oscillator 77.83 99.43

Price Performance

Historical Comparison
ADM
RMD

About ADM Archer-Daniels-Midland Company

Archer-Daniels-Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. The company is also one of the largest grain merchandisers through its extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients and is a large producer of corn-based sweeteners, starches, and ethanol.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: